Ultacan Forte (HANSAmed, Inc.)
Welcome to the PulseAid listing for the Ultacan Forte drug offered from HANSAmed, Inc.. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | HANSAmed, Inc. |
NON-PROPRIETARY NAME: | articaine hydrochloride, epinephrine bitartrate |
SUBSTANCE NAME: | ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |
ROUTE: | SUBMUCOSAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-07-11 |
END MARKETING DATE: | 0000-00-00 |
Ultacan Forte HUMAN PRESCRIPTION DRUG Details:
Item Description | Ultacan Forte from HANSAmed, Inc. |
LABELER NAME: | HANSAmed, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40; .018(mg/mL; mg/mL) |
START MARKETING DATE: | 2017-07-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52120-100_85dfc4ff-e676-4dac-9dd8-63c15af9842c |
PRODUCT NDC: | 52120-100 |
APPLICATION NUMBER: | ANDA201750 |
Other ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE Pharmaceutical Manufacturers / Labelers: